- Home
- ASND vs NBIX Comparison
ASND vs NBIX Comparison
Compare ASND & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- NBIX
- Stock Information
- Founded
- ASND 2006
- NBIX 1992
- Country
- ASND Denmark
- NBIX United States
- Employees
- ASND 1017
- NBIX N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASND Health Care
- NBIX Health Care
- Exchange
- ASND Nasdaq
- NBIX Nasdaq
- Market Cap
- ASND 12.2B
- NBIX 14.4B
- IPO Year
- ASND 2015
- NBIX 1996
- Fundamental
- Price
- ASND $208.32
- NBIX $143.19
- Analyst Decision
- ASND Strong Buy
- NBIX Strong Buy
- Analyst Count
- ASND 17
- NBIX 18
- Target Price
- ASND $245.76
- NBIX $172.06
- AVG Volume (30 Days)
- ASND 407.0K
- NBIX 884.0K
- Earning Date
- ASND 11-04-2025
- NBIX 10-28-2025
- Dividend Yield
- ASND N/A
- NBIX N/A
- EPS Growth
- ASND N/A
- NBIX 12.44
- EPS
- ASND N/A
- NBIX 4.19
- Revenue
- ASND $576,332,355.00
- NBIX $2,682,700,000.00
- Revenue This Year
- ASND $104.98
- NBIX $23.68
- Revenue Next Year
- ASND $79.91
- NBIX $18.02
- P/E Ratio
- ASND N/A
- NBIX $34.16
- Revenue Growth
- ASND 54.50
- NBIX 19.61
- 52 Week Low
- ASND $118.03
- NBIX $84.23
- 52 Week High
- ASND $216.45
- NBIX $154.61
- Technical
- Relative Strength Index (RSI)
- ASND 57.09
- NBIX 53.92
- Support Level
- ASND $195.03
- NBIX $133.62
- Resistance Level
- ASND $208.39
- NBIX $144.97
- Average True Range (ATR)
- ASND 8.24
- NBIX 4.10
- MACD
- ASND -0.46
- NBIX -0.09
- Stochastic Oscillator
- ASND 78.36
- NBIX 58.50
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.